EURONEXT N.V. 
Brussels, Lisbon, Paris - 13 March 2015 - Euronext, the primary exchange in the euro zone, today announced the launch of Euronext Private Placement Bonds (EPPB). A pan-European initiative, this new product rounds out Euronext's existing private placement bond range by extending it to Alternext. It gives issuers of private placement bonds-Euro PP, mutualized bonds or securitisation vehicles -easier access to Euronext markets in France, Belgium and Portugal, thus expanding their investor base.
Listed private placement bonds-fast, efficient access to medium- and long-term financingPrivate placement bonds give businesses a medium- and long-term debt instrument offering an alternative to bank lending, along with longer maturities. Issues can be redeemed at maturity, are flexible in size, and are competitive in terms of cost. Increasingly popular, as seen in the boom in standardized products such as Euro PPs and High Yield bonds, they reflect the combined impact of demand from issuers seeking to diversify their sources of finance and investors seeking higher returns. Listing a private placement bond issue also gives companies access to a larger group of potential investors while raising issuers' visibility and profile.
Euronext Private Placement Bonds-a simple, competitive listing processand large companies, rated or non-rated, both listed and unlisted, a simple means of raising funds through bonds.
With EPPBs, these businesses can now list private placement bond issues on Alternext using a fast, simple and standardised procedure that is also attractive in terms of cost. Accounting requirements are adapted to their needs, as are financial reporting and monitoring requirements (no prospectus, no compulsory publication of annual or half-year results, and no listing sponsor) that meet investors' requirements.
The benefits for investors are equally clear, including access to a broader private placement market that is both secure and transparent, and that guarantees trade execution.
Marc Lefèvre,Euronext's head of Business Development and Client Coverage, said "We are confident that our EPPB offer will make Euronext the market of choice for listing private placement bonds in Europe, and will boost our competitive edge in the primary bond market. Designed to meet our clients' needs in a timely and efficient way, EPPBs are a natural stage in the disintermediation of finance. They will give European companies-particularly SMEs-easier access to capital markets."
Alternext's new trading regulations are available here : www.euronext.com
Brussels - 11 March 2015 - Euronext, Petercam and the Belgian Investor Relation Association (BIRA) held their first Belgian Investor Day in Milan. The event, which was attended by 12 Belgian issuers, mainly out of the Enternext franchise, and 15 major institutional investors, aimed at raising the visibility of the Belgian listed companies among Italian investors. Euronext and Petercam strongly believe that such initiatives contribute to the growth of Belgian companies and the creation of value for the whole Belgian economy.
The event allowed investors to interact with Belgian CEOs, CFOs and Investor Relations Officers in order to learn more about investment opportunities in companies listed on Euronext Brussels. This first edition brought together a diversified group of companies in terms of size and activity sectors. The participating companies were Ackermans & Van Haaren, Ageas, Barco, Deceuninck, EVS, Galapagos, Gimv, Kinepolis, Melexis, Mobistar, Telenet and Tigenix.
This edition was a success with around 72 corporate meetings - most of them discovery ones - confirming the interest of Italian institutional investors for large, mid and small cap Belgian issuers. The attending companies represented together over 25 billion euros of market capitalisation and over 33 million euros in daily average value traded on Euronext Brussels.
Alain Baetens, Head of Listings at Euronext Brussels, declared : "Following the success of our Belgian Investor Days in other European financial centres, we are continuing the momentum by taking the same initiative here in Milan. This event is part of our efforts to help finance the real economy by connecting issuers to investors. It is a powerful way of enabling Belgian issuers to raise their visibility and broaden access across the European investor base."
Gert Potvlieghe, Head of Equity Sales at Petercam, stated: "Thanks to our in depth expertise in research based equity brokerage we have developed long lasting relationships with large institutional clients. We are pleased to support this initiative together with Euronext and the Belgian Investor Relation Association, as it enables our clients to meet new investors in addition to their contacts in the traditional financial markets."
Geoffroy d'Oultremont, Vice President Investor Relations and Corporate Communication at EVS, said: "This was the first roadshow that EVS attended in Milan. When you meet investors in a new financial centre, it is never easy as they often do not know your company. By gathering listed companies and local investors in one place, Euronext and Petercam make it very efficient for all of us. I met with 6 investors, among which 5 who did not know EVS before. This was a very good initiative."
Amsterdam, Brussels, Lisbon 6 March 2015 - Euronext, the leading exchange in the Eurozone, today celebrates International Women's Day by hosting events across its markets to highlight women's contributions to decision-making, performance, sustainability, service and long-term profits of corporations.
The 2015 celebrations at Euronext illustrate the theme "Make it Happen", encouraging effective action for advancing and recognising women in the finance industry.
AmsterdamIn Amsterdam, trading was opened by Maëlys Castella, CFO of AkzoNobel.
Maëlys Castella sounded the gong together with language institute Regina Coeli who have worked together with AkzoNobel for many years. "As a global company, we value and embrace diversity in all forms as a way of enhancing our activities," said Maëlys. "Working with different nationalities and cultures is particularly relevant for AkzoNobel, which is why our partnership with Regina Coeli is so important."
Maëlys Castella, a French citizen, became AkzoNobel's first female CFO when she was appointed in September.
Anne Louise Metz, Head of Listing for the Netherlands at Euronext said: "It's wonderful to have Maëlys Castella, CFO of AkzoNobel, opening our markets today. Her presence highlights the increasing diversity of board and senior management among Dutch corporations. We applaud the efforts of the Dutch business community to transform their boards and senior management in this manner."
BrusselsIn Brussels, trading was opened by EU Commissioner Marianne Thyssen, in charge of Employment, Social Affairs, Skills and Labour Mobility.
Marianne Thyssen visited Euronext Brussels for the opening of trading to mark her support for the numerous initiatives that incentivise the development of women in the European labour market and the finance industry in particular.
Marianne Thyssen, EU Commissioner for Employment, Social Affairs, Skills and Labour Mobility, stated: "Promoting the participation of women on the labour market and ensuring a higher presence of women in the board of directors of large listed companies is not only acting for more equality and justice between genders, it is an economic necessity to strengthen our competitiveness and revitalise our growth."
Leen Van Wambeke, Business Development Manager Financial Derivatives of Euronext Brussels, said: "Euronext has celebrated this very special day for many years. It is our way of highlighting the efforts made by many people and organisations to unlock the value and contribution of women in our society. Recognition of the value and contribution of every individual, man or woman, is what should drive us. At Euronext, we believe that gender diversity makes us stronger and enables us to make the right decisions in order to play our role in financing the economy."
LisbonIn Lisbon, the bell was rang by Teresa Morais, Secretary of State of Parliamentary Affairs and Equality, during a conference organized by Commission for Citizenship and Gender Equality.
EuronextIn honour of International Women's Day on 8 March, Euronext brought together business leaders, government officials, industry influencers, clients and partners in several events to discuss key issues impacting its global markets. In Amsterdam, Brussels, Lisbon and Paris trading was opened by women leaders and executives representing various organizations. Additionally, conferences and discussion sessions covered several topics, including the challenges of women's career development and leadership in the finance industry.
For more information about Euronext's International Women's Day 2015, please go to:
www.euronext.com/international-womens-day
Amsterdam, 5 March 2015 - Euronext, the leading exchange in the Eurozone, today announces the results of the annual review of the AEX®, AMX®and AScX®indices. The changes due to the review will be effective from Monday 23 March 2015.
AEX
Inclusion of: | Exclusion of: |
NN Group | SBM Offshore |
Vopak | Fugro |
Aalberts Industries | Klépierre |
AMX
Inclusion of: | Exclusion of: |
SBM Offshore | NN Group |
Fugro | Vopak |
IMCD | Aalberts Industries |
BE Semiconductor | Nutreco* |
Galapagos |
* Following the offer for all shares of Nutreco the Supervisor deems the company Nutreco as not eligible for this review. The Supervisor has made this decision based on the acceptance level of the offer as announced by SHV Holdings.
AScX
Inclusion of: | Exclusion of: |
Yatra Capital | BE Semiconductor |
Macintosh Retail Group | Galapagos |
Batenburg Techniek | Groothandelsgebouwen |
In the event of a take-over or other exceptional circumstances, the Compiler of the indices has the right to revise the selection during the period before the effective date of the review.
Review AEX family
The AEX family is reviewed quarterly (March, June, September, December). The full annual review is in March. The June, September and December reviews serve to include new entrants in case the index consists of less than the standard number of constituents and to facilitate inclusion of highly ranked non- constituents, for example recently listed companies.
| Press release | en | |||
Paris, 5 March 2015 -Euronexttoday announced the results of the reweighting of the CAC family, that took place after close of the markets on Thursday 5 March 2015.The changes due to the review will be effective from Monday23 March 2015.
Results of the Quarterly Review
CAC 40® Index:Inclusion of: | Exclusion of: |
PEUGEOT | GEMALTO |
Inclusion of: | Exclusion of: |
GEMALTO | PEUGEOT |
HERMES INTL | CGG |
KLEPIERRE | LAGARDERE S.C.A. |
Inclusion of: | Exclusion of: |
HERMES INTL | CGG |
KLEPIERRE | LAGARDERE S.C.A. |
Inclusion of: | Exclusion of: |
CGG | AREVA |
LAGARDERE S.C.A | HERMES INTL |
ELIOR | KLEPIERRE |
HAVAS |
Inclusion of: | Exclusion of: |
ELIOR | AREVA |
HAVAS |
Inclusion of: | Exclusion of: |
AREVA | ELIOR |
ORCO PROPERTY GRP | AUGROS COSMETICS |
OREGE | COURTOIS |
PIXIUM VISION | DOCK.PETR.AMBES AM |
VIADEO | INSTALLUX |
LAFUMA | |
SIGNAUX GIROD | |
SODITECH ING. | |
TIPIAK | |
TONNA ELECTRONIQUE |
Inclusion of: | Exclusion of: |
CGG | HERMES INTL |
LAGARDERE S.C.A. | KLEPIERRE |
HAVAS | AUGROS COSMETICS |
ORCO PROPERTY GRP | COURTOIS |
OREGE | DOCK.PETR.AMBES AM |
PIXIUM VISION | INSTALLUX |
VIADEO | LAFUMA |
SIGNAUX GIROD | |
SODITECH ING. | |
TIPIAK | |
TONNA ELECTRONIQUE |
Inclusion of: | Exclusion of: |
HAVAS | AUGROS COSMETICS |
ORCO PROPERTY GRP | COURTOIS |
OREGE | DOCK.PETR.AMBES AM |
PIXIUM VISION | INSTALLUX |
VIADEO | LAFUMA |
SIGNAUX GIROD | |
SODITECH ING. | |
TIPIAK | |
TONNA ELECTRONIQUE |
The compiler of the indices retains the right to change the published selection above in connection with any mergers, takeovers, suspension or resumption of trading during the period before the
effective date of the annual review.
Review CAC family
The CAC family is reviewed quarterly (March, June, September, December). The full annual review is in September. The annual review serves to include new entrants in case the index consists of less than the standard number of constituents and to facilitate inclusion of highly ranked non-constituents, for example recently listed companies.
Amsterdam, Brussels, Lisbon, London and Paris - 4 March 2015 - Euronext, the leading exchange in the Eurozone, today announced trading volumes for February 2015.
- The February 2015 average daily transaction value on the Euronext cash order book stood at €8,247 million (+24% compared to February 2014).
- In February 2015, the average daily volumes on equity index derivatives were down at 225,995 contracts (-15% compared with February 2014), and the average daily volumes on individual equity derivatives were down at 264,767 contracts (-8% compared to February 2014).
- Activity on commodity derivatives remained strong in February with an average daily volume of 52,474 contracts traded, up 18% when compared to February 2014.
- Euronext had nine new listings in February that altogether raised more than €2 billion. In addition €1,211 million of follow-on equity was raised on Euronext by issuers, of which €984 million by EnterNext SMEs. €9.8 billion was raised in corporate bonds.
- Warrants & Certificates have reached a new record high with now over 53,000 listings live at the end of February (+45% compared to end of Feb 2014).
Please see tables attached
Brussels, 26 February 2015: Euronext today announced the results of the yearly review for the BEL 20®, BEL Mid®, and BEL Small®.
The changes due to the review will be effective from Monday 23 March 2015.
Results of the March 2015 Review
BEL 20®:No changes in the composition of the index
BEL Mid®:inclusion of | exclusion of |
| None | FLUXYS BELGIUM |
inclusion of | exclusion of |
| ARGEN-X | None |
The compiler of the indices retains the right to change the published selection above in connection with any mergers, takeovers, suspension or resumption of trading during the period before the effective date of the annual review.
Review BEL 20®, BEL Mid®, and BEL Small®
The BEL 20®, BEL Mid®, and BEL Small® is reviewed quarterly (March, June, September, December). The full annual review is in March. The June, September and December reviews serve to include new entrants in case the index consists of less than the standard number of constituents and to facilitate inclusion of highly ranked non-constituents, for example recently listed companies.
Amsterdam, Brussels, Lisbon, London and Paris - 25 February 2015 - Euronext today announced its results for the full year of 2014.
- Third party annual revenue increased by +9.0% on an adjusted basisto €458.5 million (FY 2013 adjusted: €420.5 million), or +18.6% on a reported basis (FY 2013 reported: €386.7 million)
- Substantial reduction in operational expenses excluding depreciation and amortization: -11.4% compared to FY 2013 adjusted1(decrease by -5.2% compared to FY 2013 reported)
- Full-year EBITDA margin of 45.8% - €38million of efficiencies already achieved
- Revised commitment to deliver total net efficienciesof €80 million by the end of 2016 - the €60 million efficiencies2originally mentioned will be delivered by the end of H1 2015 (run-rate basis)
- A €0.84 per share dividend will be proposed for approval at the AGM on 6 May 2015, representing a 50% payout ratio on net profit.
"Over the past 12 months we have been focussed on the execution of our ambitious strategy. Today's results are evidence of our ability to drive Euronext forward, underscored by continued strong growth in our revenue, a substantial reduction in our expenses and attaining an EBITDA margin of 45.8%. We will continue to optimize Euronext and we are committing to increase our efficiencies to €80 million by the end of 2016 on a run-rate basis. We have appointed a number of highly accomplished individuals to Euronext this year and I am extremely proud of the talent that we now have within the group, creating a superior team in this industry. Together we will continue our work to build Euronext into a leading financing centre and thereby position us as a champion in Europe," said Dominique Cerutti, CEO and Chairman of the Managing Board of Euronext NV.
Read full press release
for the nine month period ending 31 December 2013 the changes in third party revenue and operational expenses have also been included when adjusted for the new derivative clearing agreement with LCH.Clearnet. This was included based on our estimate of the amount of revenue we would have received and the amount of associated expenses we would have paid under the Derivatives Clearing Agreement, based on our actual trading volume for the periods presented and assuming the Derivatives Clearing Agreement had been in effect from 1 April 2013, see also specific paragraph and reconciliation pages 6 and 7.
pre tax operating optimisation and efficiencies. Net amount, on a run-rate basis, ie taking into account the full year impact of any cost saving measure to be undertaken before the end of the period mentioned.
Raises €18 million, market capitalisation totals €55 million
Paris - 20 February 2015- EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs,today congratulated Ecoslops, a company specialised in transforming oil residues from shipping into marine fuels, on its successful listing on Alternext in Paris.
Founded in 2009, Ecoslops uses an innovate technology to transform oil residues from shipping into new recycled marine fuels, giving slops and sludge a second life. Demand is strong and its solution offers stakeholders an economically viable and ecologically sound solution. Its first industrial site is already up and running and will increase capacity gradually. Building on this success, Ecoslops plans to step up the pace of growth by signing three new projects by 2017 and expanding its collection capacity.
Ecoslops (ticker symbol: ALESA) was listed through the admission to trading of 3,053,520 ordinary shares, including 1,000,000 new shares issued under a Global Offering after full exercise of the extension clause and the over-allotment option.
The admission and issue price of Ecoslops shares was set at €18 per share. Market capitalisation on the day of listing was nearly €55 million, and the operation raised a total of €18 million.
Michel Pingeot, Chairman and CEO of Ecoslops said: "We are proud that so many investors have shown interest in our company and want to thank all of our shareholders for their trust. Listing has given us the resources we need to become a major player in the transformation of shipping oil residues and continue to grow."
Eric Forest, Chairman and CEO of EnterNext, noted: "We are delighted to welcome Ecoslops to Alternext. Listing will enable this energy transition specialist to step up the pace of its business development and raise its profile with investors. Ecoslops is now part of the very dynamic group of eco-industry SMEs listed on our markets. This is also the beginning of a lasting relationship with EnterNext, whose teams will be working hard to assist and serve this fast-growing company."
To celebrate Ecoslops's listing, Michel Pingeot gave a €15,000 cheque to the French association La Société Nationale de Sauvetage en Mer (SNSM).
Small and medium-size companies
The Global Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries
Brussels - 17 February 2015 - Euronext Brussels announces the successful admission to listing of the 15 years benchmark Government bonds issued by the Belgian Debt Agency, responsible for public debt management in Belgium.
The Debt Agency's main objective is to minimize the financial costs related to the federal debt, taking into account market and operational risks in line with the general objectives of the budgetary and the monetary policy. They are a specific entity within the General Administration of the Treasury and were created to better cope with the challenges of financing the sovereign in the context of the European Monetary Union. The Agency executes the financial operations, which consist mainly of issuing loans and managing the Belgian cash position. They are also active on the market of derivatives.
The bonds (OLO 75) are issued as a syndicated transaction joint lead managed by four major banks and admitted to listing on Euronext Brussels on payment date. They were issued for an amount of € 4 billion, bear a 1% coupon and mature on the 22nd of June 2031.
Anne Leclerq, Director Treasury & Capital Markets of the Belgian Debt Agency, added: "Our bonds are bought by a diversified group of institutional investors spread all over the world. However, as 42% of OLOs are held by Belgian investors, we believe that listing on Euronext Brussels is important and contributes to the promotion of the Belgian debt instrument."
Vincent van Dessel, CEO of Euronext Brussels, said: "Euronext historically built up strong ties with the Federal Government of Belgium in providing services to the General Treasury Administration. The capital markets enable governments to address their debt funding needs, both short and long term. The listing of its bonds by the Belgian Debt Agency highlights Euronext's position as a leading stock exchange and financing centre in Europe."
Alain Baetens, Head of Listings of Euronext Brussels, added:"Our partnership with the General Treasury Administration is rooted in strong execution and market access deliverables, providing first class debt services to support managing the Belgian cash and funding position. We are very honoured that all public authority levels in Belgium, whether national, regional or local, actively use our markets to manage their financial strategies, provide connection with international investors and ultimately drive the country's prosperity and welfare."
Today, to celebrate the introduction of the new bonds, Anne Leclerq, Director Treasury & Capital Markets of the Belgian Debt Agency, rang the bell in Brussels to open the trading on Euronext's European markets. She was accompanied by Vincent Van Dessel, CEO of Euronext Brussels, and Johan Verschelden, Head of Brussels Market Development, Euronext Brussels.
BNP Paribas Fortis, Crédit Agricole CIB, JP Morgan et SG CIB acted as Joint Book Runners.
Extension of flagship milling wheat contract to Johannesburg Stock Exchange
Paris and Johannesburg - 16 February 2015- Euronext today announces that it has signed a license agreement with the Johannesburg Stock Exchange ("JSE") providing the JSE with the right to list the flagship Milling Wheat contract currently traded on Euronext. The aim of the agreement is to extend access to the global benchmark Milling Wheat contract by broadening its international exposure to a wider audience.
In this context, through partnering with the largest exchange in the region, the agreement also extends Euronext's reach into Africa, which according to International Monetary Fund forecasts, will be the world's second fastest-growing region next year, expanding 5.75 per cent.
The license agreement signed between the two exchanges is reciprocal, enabling each exchange the right to use the settlement prices and brands for the other's commodities contracts. JSE will initially list the Euronext Milling Wheat contract, and this agreement can be extended to include its contracts for Rapeseed and Corn.
Nicholas Kennedy, Head of Commodities Business Development at Euronext, said, "Euronext is delighted to be able to offer its global benchmark wheat contract to the Johannesburg Stock Exchange under its own branding. This agreement fits within our larger strategy of broadening our reach in a selective manner with targeted partners. In this particular case, it further strengthens our high quality franchise through greater visibility while providing JSE with the opportunity to offer a broader range of products to its clients looking to hedge their volatility in the wheat agricultural area."
Chris Sturgess, Director of Commodities & Key Client Management at the JSE, said, "The JSE is pleased to make available to its clients Euronext's benchmark Milling Wheat contract. This will give local market participants easy access to the European wheat market, adding a wider choice of trading opportunities where participants already access South African and North American wheat markets. The South African exchange looks forward to the growth of the strategic relationship with Euronext through which we are jointly able to offer a wider range of products across our client base."
Raises €12.7 million with market capitalisation of €51 million
Paris - 16 February 2015 - EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs,today announced the listing of French video-games publisher Focus Home Interactive on Alternext in Paris.
Founded in 1995, Focus Home Interactive is France's third largest publisher of video games, working with development studios to coordinate production, marketing, sales and finance. The company's successful original titles include Blood Bowl, Tour de France, Sherlock Holmes and Farming Simulator, and it sold 4 million games worldwide in 2014.
Focus Home Interactive (ticker code: ALFOC) was listed through the admission to trading of 1,055,386ordinary shares, including 351,795 existing shares and 703,591 new shares issued under a Global Offering after full exercise of the extension clause.
The admission and issue price of Focus Home Interactive shares was set at the €12.07 per share. Market capitalisation on the day of listing was nearly €51 million. The operation raised €12.7 million.
Jean-Pierre Bourdon, Chairman of the Management Board of Focus Home Interactive said: "We are delighted that so many people have joined us. I would like to thank all of the new investors, professionals and individuals, who will be sharing in our success-over the long term, I hope. I also want to thank our Managing Partner Cédric Lagarrigue and our CFO Deborah Bellangé, who have worked tirelessly with me to bring our project to the financial community. Finally, I would like to acknowledge all of our employees and partners who, through their own engagement, have made this operation such a success. The funds raised will enable us to develop new games with great potential and continue to promote our existing successes while strengthening our worldwide presence."
Eric Forest, Chairman and CEO of EnterNext said: "We extend hearty congratulations to Focus Home Interactive on its successful listing on Alternext. It's a pleasure to work with this innovative video game specialist, which is also the seventh company to list on markets covered by EnterNext since the beginning of 2105. Listing will finance its growth and international expansion, and also raise its profile."
To celebrate Focus Home Interactive's listing, Jean-Pierre Bourdon gave a €10,000 cheque to Les Restaurants du Coeur, a French charity for people in need.
Small and medium-size companies.
TheGlobal Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries
Raises €12 million with market capitalisation of €45.8 million
Paris - 13 February 2015- EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs[1], today congratulated Tronics, a designer and manufacturer of innovative nano- and micro-systems, on its successful listing on Alternext in Paris.
Founded in 1997 in Grenoble, France, Tronics is a recognized technological leader in nano- and micro-systems with high added value. The company designs, manufactures and sells custom and standard products on industrial, aeronautics & security, medical and consumer markets. Its technology platforms are currently protected by a portfolio of 25 families of patents resulting from 15 years of R&D.
Tronics (ticker code: ALTRO) was listed through the admission to trading of the 3,470,408 ordinary shares making up its equity, including 909,091 new shares issued under a Global Offering[2] that included full exercise of the extension clause and the over-allotment option. The operation raised €12 million including the issuing premium.
The admission and issue price of Tronics shares was set at the top of the price range at €13.20 per share. Market capitalisation was €45.8 million on the day of listing.
Pascal Langlois, CEO of Tronics said: "We are particularly proud and happy at the success of our listing. We will use the capital raised to step up the pace of our international development, boost our brand, strengthen our engineeering teams, and pursue strong innovation in nano- and micro-systems with high added value.
Eric Forest, Chairman and CEO of EnterNext, said: "We are delighted with Tronics' successful listing on Alternext, which attracted many investors, both individual and institutional. Tronics is a French high-tech business, and testifies to the high potential of innovative European companies that EnterNext wants to see expand their stockmarket presence. This new stage in its development will give it greater visibility on our markets."
Small and medium-size companies
The Global Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries.
€750 million raised, market capitalisation of €1.5 billion
Paris - 11 February 2015 - Euronext today celebrated the listing of Elis, Europe's leading specialist in the rental and maintenance of professional clothing and textile articles, in Compartment A of the regulated market in Paris.
Elis is a leading multi-services group in Europe and Brazil, specialised in the rental and maintenance of professional clothing and textile articles, as well as hygiene appliance and well-being services. With 18,500 employees spread across 10 countries, Elis today services more than 240,000 businesses of all sizes in the hotel, catering, healthcare, industrial, retail and services sectors, thanks to its network of 256 production and distribution centres and 13 clean rooms, which guarantees it an unrivalled proximity to its clients.
Elis (ticker code: ELIS) was listed through the admission to trading of the 114,006,167 shares making up its equity, including 57,692,306 shares issued under a Global Offering, of which 3,846,153 existing shares and 53,846,153 new shares, before any exercise of the Over-Allotment Option.
The placement was very successful with domestic and international investors, both retail and institutional.
The admission and issue price of Elis shares was set at €13.00 per share. Market capitalisation was €1.5 billion on the day of listing, and the transaction raised a total of €750 million.
Xavier Martiré, Chairman of Elis Management Board, said: "We are delighted with the success of Elis's IPO. This very positive response reflects investor confidence in our business model, our strategy and our growth potential. Thanks to the support of our shareholders and our unique positioning, Elis has the assets it needs to continue expanding in France and internationally."
Anthony Attia, CEO of Euronext Paris, said: "We congratulate Elis,the leading player in its sector in Europe and Brazil, on today's very successful listing. As 2015 gets under way, the trust Elis has placed in Euronext markets confirms our role as the benchmark for companies with strong international growth potential. Its listing underscores the vibrancy of the primary market in France and testifies once again to Euronext's core business: financing the European economy by helping issuers tap capital markets more easily."
Marc Lefèvre, Head of European Business Development and Client Coverage, Listings Europe, at Euronext, added: "We are absolutely delighted to welcome Elis to our regulated market in France. The success of this eagerly awaited transaction gets 2015 off to a promising start, sending a strong, positive signal. It reflects investors' enthusiasm for large transactions on the French market. Elis is a remarkable ambassador for successful French companies, benefiting fully from the liquidity, visibility and quality of service associated with a listing on Euronext."
The Global Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries
Raises €9.6 million with market capitalisation of €33 million
Paris - 10 February 2015 - EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs, today announced the listing of Safe Orthopaedics, a French medical technology company, in Compartment C of the Euronext Paris regulated market.
Founded in 2010, Safe Orthopaedics develops and markets an innovative range of sterile implants and associated single-use surgical instruments, designed to optimise spinal surgery and make it safer and less costly. By eliminating the reuse of surgical instruments, Safe Orthopaedics reduces the risk of infection, avoids the cumbersome, unreliable logistics of instrument sterilisation, and limits hospital costs.
Safe Orthopaedics (ticker code: SAFOR) was listed through the admission to trading of the 12,937,903 ordinaryshares making up its equity, including 3,750,641new shares issued under a Global Offering.
The admission and issue price of Safe Orthopaedics shares was set at €2.55 per share. Market capitalisation was €33 million on the day of listing, and the transaction raised a total of €9.6 million.
Yves Vignancour, CEO of Safe Orthopaedics said: "Our listing on Euronext is a key stage in stepping up the pace of our product innovation and international growth. We would like to thank our existing shareholders, as well as all those who have joined us now, for their trust and support in making spinal surgery safer and more effective."
Eric Forest, Chairman and CEO of EnterNext said: "We congratulate Safe Orthopaedics, an innovative spinal surgery specialist, on its listing on Euronext-a move that brings it into the dynamic 66-member family of life science businesses listed on Euronext markets. This operation will enable the company to support and accelerate deployment of its innovative and ambitious strategy on global markets."
Small and medium-size companies
The Global Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries
Paris - 6 February 2015 - EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs, today congratulatedPoxel, a biopharmaceutical company developing drugs for diabetes, on its successful listing in Compartment C of the Euronext Paris regulated market.
Based in Lyon, France, and founded in 2009, Poxel is a biopharmaceutical company that develops innovative, first-in-class drugs for metabolic diseases, in particular Type 2 diabetes. The company was spun off from Merck Serono, a past leading global player developing and marketing drugs for the treatment of metabolic disorders. Poxel has a rich pipeline of new-generation, high-potential products including Imeglimin, the first oral diabetes drug candidate, offering patients better control of the pathology's progression by targeting directly the two main defects of diabetes.
Poxel (ticker symbol: POXEL of the 17,346,686 shares making up its equity, including 3,749,999 new shares issued under a Global Offering after the partial exercice of the extension option and before any exercise of the over-allotment option.
The admission and issue price of Poxel shares was set at €6.66 per share. Market capitalisation was €116 million on the day of listing, and the transaction raised a total of €25 million.
Thomas Kuhn, CEO of Poxel, said: "We are delighted to announce today the success of our Initial Public Offering on the Euronext in Paris. This achievement is the result of the contribution of each of our shareholders - longstanding and new, our partners and our members of staff, who I would like to thank wholeheartedly for their support and participation in this major success. This IPO will enable us to continue the development of our diabetes drug candidates, and we remain fully focused on meeting the upcoming challenges that await us".
Eric Forest, Chairman and CEO of EnterNext noted: "We are delighted to welcome Poxel, a Lyon-based company and one of the first biotechnology business to list on our markets in 2015. Listing with Euronext will raise Poxel's profile with investors and enable it to benefit from the expertise and assistance of EnterNext's teams. Today there are 64 biotech and medtech companies listed on Euronext markets, making us the European benchmark for sector companies seeking financing to support the next stages of their development and looking to expand on international markets. This is also a red-letter day for Euronext's European markets since we are today welcoming three new listings-in Paris, Brussels and Amsterdam- a performance which perfectly illustrates our positioning as one of Europe's major centres for raising capital."
Small and medium-size enterprises.
Company shares will be traded on as-if under a single trading line "POXEL AIW" up to and including 9 February 2015.
The Global Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries
Poxel in Paris, Bone Therapeutics in Brussels and GrandVision in Amsterdam.
Amsterdam - 6 February 2015 - Shares in GrandVision N.V., the global leader in optical retail, today began trading on Euronext's Amsterdam market, after its successful Initial Public Offering (IPO). In total approximately €1 billion was raised by the company.
GrandVision (ticker code: GVNV) is the world's largest optical retailer with the widest geographical reach and the biggest optical retail store network. The Company serves customers on the highstreet, in commercial shopping centers and online. It operates a portfolio of 33 leading optical retail banners with over 5,600 stores in 43 countries throughout Europe, Latin America, the Middle East and Asia.
After opening, the first market price was €20.00 per share. The total market capitalization of the company at opening was over €5 billion.
Theo Kiesselbach, CEO of GrandVision, said, "We are very pleased to complete our IPO with today's listing on Euronext. We have seen strong demand from investors who are attracted by GrandVision's unique platform for future growth combined with strong cash flow generation. We have also been able to illustrate the passion and dedication of the many optical experts in the over 5,600 GrandVision stores as they provide high quality and affordable eye care to customers around the world. We would like to welcome our new shareholders and look forward to continuing our successful international growth story as a listed company in the years to come."
"We congratulate GrandVision on their successful IPO," said Maurice van Tilburg, CEO of Euronext Amsterdam: "GrandVision's listing will give the company access to a global investor base. We are seeing more companies turning to us to raise both debt and equity. Today alone, three new companies are holding IPOs across the Euronext markets, reinforcing our strategy as a European leading capital raising centre."
Anne Louise Metz, Head of Listings of Euronext Amsterdam, added: "We are pleased to welcome GrandVision to our market and we look forward to supporting the company and its investors with the highest levels of service, liquidity and market quality. After hosting some of the largest and most successful IPOs in Europe last year, this transaction reaffirms Euronext's position as the venue of choice for large multinational listings."
GrandVision celebrated the company's listing by having Theo Kiesselbach sound the gong which denotes the opening of trading on Euronext.
Bone Therapeutics celebrated its successful admission to listing on Euronext Brussels and Euronext Paris in the presence of the Vice-President and Minister of Economy of the Walloon Government, Jean-Claude Marcourt
Brussels, Paris, 6 February 2015 - EnterNext, the Euronext subsidiary designed to promote and grow the market for SMEs, today welcomed Bone Therapeutics to the regulated markets of Euronext Brussels and Euronext Paris.
Bone Therapeutics is an advanced biotechnology company with a unique approach to the development of cell therapy products for bone fracture repair and fracture prevention. The company is creating a new and unique treatment approach using differentiated bone-forming cells administered via a minimally invasive percutaneous procedure, expected to offer significant benefits over the current standard-of-care that often involves heavy surgery and long recovery periods.
Bone Therapeutics (ticker code: BOTHE) issued 2,012,500 new shares at a reference price of €16.00 per share equivalent to €32.2 million in a 2.5 times oversubscribed initial public offering. Based on the reference price, the total market capitalization of Bone Therapeutics at the opening stood at €104.8 million.
Enrico Bastianelli, CEO of Bone Therapeutics, said : "This is an exciting day for Bone Therapeutics as we welcome a number of high quality investors to our share register and begin our life as a public company. We are delighted to be joining Euronext Brussels and Paris at a time when the exchange is offering strong support for life sciences companies and impressive returns. The funds we have raised will help to support and accelerate the development of Bone Therapeutics, in particular by facilitating the progression of our two pivotal Phase III trials and three Phase I/II trials, helping us to initiate trials in the US and to optimize our production. We look forward to our life as a public company listed on these two prestigious exchanges and to what we hope will be an exciting and rewarding journey bringing our innovative pipeline towards commercialization."
Vincent Van Dessel, CEO of Euronext Brussels, declared: "We are delighted to welcome Bone Therapeutics to Euronext Brussels and Euronext Paris. This dual listing demonstrates the attractiveness of public equity markets as a source of financing for companies to help them achieve the next stage in their development. Today alone, three new companies are holding IPOs across the Euronext markets in Amsterdam, Brussels and Paris, reinforcing our strategy as a European leading capital raising centre."
Alain Baetens, Head of Listings of Euronext Brussels, said: "The successful dual IPO of Bone Therapeutics confirms the promising trend observed throughout 2014 with record volumes raised on Euronext Brussels. Our EnterNext Biotech franchise is a leader among European exchanges with over 30 issuers accounting for a market capitalization of €6.2 billion. Our Nextbiotech index outperformed most of the main European indices over the last 5 years, and the diversified placement of Bone Therapeutics also confirms the strong return of retail investors on the capital markets in Belgium. Euronext Brussels actively participated in centralising the Public Offers in connection to the listing of Bone Therapeutics securities."
Jean-Claude Marcourt, Vice-President of the Walloon Government, Minister of Economy, Industry and Innovation, commented: "This initial public offering definitely contributes to the creation of a major company in our country as Bone Therapeutics already displays all the qualities of a large company. As a spin-off of the Université Libre de Bruxelles created in 2006 and active in the development of cellular products, Bone Therapeutics grew from 3 employees at the end of 2007 to about 80 today. As from the start, the Walloon Region has accompanied the company in every stages of its development. Their future move to Gosselies will allow to maintain this added value for the economy of our region and the employment created by this project. Wallonia ensures once more a unique know-how in life sciences and the biotech sector. Some other companies should follow the same path shortly given the good results of their research and development."
To celebrate the listing, Enrico Bastianelli, CEO of Bone Therapeutics, and Michel Helbig de Balzac, Chairman of Bone Therapeutics, rang the bell in Brussels to open trading on Euronext's European markets. They were accompanied by Minister Jean-Claude Marcourt, Vice-President of the Walloon Government, Minister of Economy, Industry and Innovation.
Paris - 5 February 2015 - Euronext, the primary exchange in the Eurozone, is announcing the launch at the beginning of March 2015 of its new premium milling wheat no. 3 contract, subject to final regulatory approval. Based on premium specifications, this new contract consolidates Euronext's expertise in milling wheat and is fully adapted to the needs of stakeholders in the agrifood industry, providing a higher quality contract available for trading from September 2015.
The launch of the new premium milling wheat contract no. 3 is aimed at strengthening Euronext's offering in one of its flagship products, now a benchmark for the wheat industry in Europe. Developed in partnership with industry requirements as expressed in 2014 surveys, this new instrument for physical delivery meets enhanced qualitative criteria:
- Protein content: minimum 11%
- Hagberg falling number: minimum 220 seconds
- Minimum 76 kilos per hectoliter
Delivery sites for the new contract include silos operated by Euronext's partners of reference for milling wheat-Sénalia, Socomac in Rouen and Sica Nord-Céréales in Dunkirk-as well as new silos in Nantes and Bordeaux operated by InVivo, France's largest agricultural cooperative.
Commenting on the new partnership, Laurent Martel, General Manager, Director, Agricultural Division inVivo, said "We are delighted to partner as delivery silo in the launch of Euronext's new milling wheat contract. Our aim is to better meet industry demand for premium quality milling wheat. We hope that InVivo will contribute to the success of this contract."
Anthony Attia, CEO of Euronext Paris, said: "Our milling wheat futures contract is now the European benchmark for prices on physical delivery markets. Over the past 15 years, this contract has built a name for itself based on our in-depth understanding of industry needs and a focus on international growth. Today our premium milling wheat no. 3 contract is fresh proof of our commitment to stakeholders in agriculture and will help strengthen Euronext's positioning as a major player in commodities markets."
Olivier Raevel, Head of Commodities at Euronext, noted: "The launch of our new premium milling wheat no. 3 contract reflects our commitment to providing greater flexibility and transparency to our partners in the French and European grain industry, with whom we work closely. By raising the bar for wheat quality and expanding the number of physical delivery points, we are actively contributing to a quality focused shift in industry standards. 2014 saw two record highs in daily trading in our flagship contract, reflecting its attractiveness to our increasingly global client base. Adding this new contract will boost overall liquidity and exports."
Amsterdam, Brussels, Lisbon, London and Paris - 4 February 2015 - Euronext, the leading exchange in the Eurozone, today announced trading volumes for January 2015.
- The January 2015 average daily transaction value on the Euronext cash order book stood at €8,630 million (+31% compared to January 2014).
- In January 2015, the average daily volumes on equity index derivatives were significantly up at 298,375 contracts (+12% compared with January 2014), while the average daily volume on individual equity derivatives was down at 240,899 contracts (-19% compared with January 2014).
- The activity on commodity derivatives remained strong in January with an average daily volume at 53,653 contracts traded, up 7% when compared to January 2014.
- Euronext had two new listings in January. €7,562 million of follow-on equity was raised on Euronext by issuers, of which €28 million by EnterNext SMEs. €6.5 billion was raised in corporate bonds.
- The Exchange Traded Products segment was particularly dynamic in January with an average daily transaction value up 77% compared to January 2014. Also on 23 January this segment reached a new record high since August 2011 at €1,031 million traded.
Please see tables attached
| Please see tables attached | en | |||
|
distributed by
|
